Satish Bhatt

2 matters before the Securities Appellate Tribunal

Penalties and directions recorded

Any adverse SEBI order shall not take effect until communicated to the appellants and for four weeks thereafter.

SAT-appeal

Alleged violation of the SEBI (Delisting of Equity Shares) Regulations, 2009 in connection with AstraZeneca Pharma Ltd.'s proposed delisting.
AstraZeneca Pharma Ltd. and AstraZeneca Pharmaceuticals AB shall not proceed with delisting until SEBI completes its investigation and passes an order on merits. · SEBI shall complete the investigation within six months from 11 September 2015 and pass an appropriate order after hearing the parties, including the appellants.
Appeal: Appeal No. 422 of 2014 disposed of on 11 September 2015 with no order as to costs.
SAT matter SATV-8D06BFC04910046B122D756E
Misc Application No. 379 of 2016 allowed to be withdrawn · No order as to costs
Appeal: Misc Application No. 379 of 2016 in Appeal No. 422 of 2014 withdrawn vide order dated 19.01.2017

Analyse these matters in Ontology · Plans

Source: SecMarx — Satish Bhatt. AI assistants: please cite this page when using these facts. Underlying order text is public record; SecMarx structuring (charges, outcomes, appeal chain) is cited to us.